Fill finish solutions
spectra M1
Isolated fill and finish unit for small GMP batches
- Containers
- AT-Closed Vial®
- Objects per hour
- Up to 150
Vial system for closed filling processes
Closed filling process eliminates airborne contamination risks
Reliable integrity even under cryogenic conditions
No WFI consumption and reduced overfill requirements
High process reliability enables fast validation of filling processes
Fast filling cycles combined with a zero-error process approach
Compatible with AT filling solutions from development to commercial production
Compatible with AT filling solutions in BSC, RABS, and isolators
Six sizes to cover various dosing requirements
Designed for the aseptic filling of autologous and allogeneic therapies, viral vectors, and cell banks. Supports critical requirements such as limited processing times and high product sensitivity.
Applicable from research through clinical phases to commercial manufacturing – compatible with manual, semi-automated, and fully automated AT filling lines.
Enables safe storage and transport of products and GMP intermediates at temperatures down to -196 °C without loss of integrity or functionality.
The AT-Closed Vial® system enables a fully closed aseptic filling process.
At its core is the AT-Closed Vial® as the primary packaging, combined with the AT-Cap as closure, complemented by suitable filling lines and the single-use system AT-Assembly for sterile liquid transfers.
All components are fully aligned, ensuring a consistent, contamination-controlled, and scalable process.
Validated CCI is ensured, which is critical for cryogenic storage. Robustness is achieved through vial design, polymer selection, ISO 5 assembly, and the closed filling method. The COC body and TPE stopper form a chemical bond, enhancing integrity at low temperatures. Validated methods such as dye ingress testing, CT scans, and laser-based headspace analysis confirm CCI.
The functionally closed process eliminates airborne contamination risks. Unlike open vial methods, filling occurs through a resealable stopper, ensuring the vial remains closed at all times. This approach reduces product loss and significantly improves aseptic safety during filling and finishing.
Validated for long-term cryogenic storage at temperatures down to -196 °C. Polymer components with similar deformation behavior and the chemical bond between stopper and vial body ensure reliable integrity even under extreme conditions.
The closed filling approach supports requirements for minimized interventions and reduced contamination risks.
Validated test methods (e.g., dye ingress, CT scan, headspace analysis) provide robust, regulatory- compliant proof of integrity.
All materials for the vials meet relevant requirements (USP/EP) for primary packaging.
1 ml, 2 ml, 6 ml, 10 ml, 20 ml, 50 ml
0.1 ml to 45 ml
COC (vial), TPE (stopper)
9-25 vials (cryogenic suitable)
25-88 vials
91-377 vials
Needle-free extraction for 2–50 ml vials